Lingua: Tedesco
Editore: Gräfe und Unzer Verlag, München, 1994
ISBN 10: 3774211914 ISBN 13: 9783774211919
Da: Buchstube Tiffany56, Barsbüttel, Germania
Prima edizione
EUR 5,00
Quantità: 1 disponibili
Aggiungi al carrelloSoftcover. Condizione: Wie neu. Ohne Schutzumschlag. 1. Auflage. Ohne Eier und Milch: Richtig essen bei Allergien gegen Hühnereiweiss und Kuhmilcheiweiss; Rezepte, die der ganzen Familie schmecken. Mit Warenkunde. sowie einer medizinischen Einführung, 96 Seiten, 1. Auflage 1994!
Lingua: Inglese
Editore: Berlin/ Heidelberg, Springer Berlin., 2012
ISBN 10: 3642261434 ISBN 13: 9783642261435
Da: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germania
EUR 18,00
Quantità: 1 disponibili
Aggiungi al carrello2010. 16 x 24 cm. XIV, 231 S. XIV, 231 p. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. (Recent Results in Cancer Research). Sprache: Englisch.
Da: SpringBooks, Berlin, Germania
EUR 19,95
Quantità: 1 disponibili
Aggiungi al carrelloSoftcover. Condizione: As New. Like new. Immediately dispatched from Germany.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 127,96
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Revaluation Books, Exeter, Regno Unito
EUR 165,86
Quantità: 2 disponibili
Aggiungi al carrelloPaperback. Condizione: Brand New. 2010 edition. 248 pages. 9.20x6.10x0.56 inches. In Stock.
Da: preigu, Osnabrück, Germania
EUR 104,15
Quantità: 5 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Angiogenesis Inhibition | Rüdiger Liersch (u. a.) | Taschenbuch | xiv | Englisch | 2012 | Springer | EAN 9783642261435 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 2012
ISBN 10: 3642261434 ISBN 13: 9783642261435
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 117,69
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 201,38
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Da: Buchpark, Trebbin, Germania
EUR 110,08
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 160,49
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New. pp. 248.
Da: Revaluation Books, Exeter, Regno Unito
EUR 234,53
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 231 pages. 9.00x6.00x0.50 inches. In Stock.
Lingua: Tedesco
Editore: Vieweg+Teubner Verlag Auflage: 5, bearb. u. erg. Aufl. 2007 (26. Juli 2007), 2007
ISBN 10: 3835101366 ISBN 13: 9783835101364
Da: BUCHSERVICE / ANTIQUARIAT Lars Lutzer, Wahlstedt, Germania
EUR 57,99
Quantità: 1 disponibili
Aggiungi al carrelloSoftcover. Condizione: gut. Dieses Lehrbuch wurde für Studierende der Hochschulen, für Praktiker in der Windkraftindustrie und Neugierige jeder Art geschrieben. Es basiert auf den Lehrveranstaltungen, die die Herausgeber Prof. Dr.-Ing. Robert Gasch und Dr.-Ing. Jochen Twele an der Technischen Universität Berlin halten. Schon mit der 1. Auflage von 1991 wurde es zum Standardlehrwerk. Die Autoren der 16 Kapitel arbeiten nahezu ausnahmslos seit vielen Jahren in der Windkraftbranche. Für die 5. Auflage wurde das Kapitel 4 zum Wind und zur Windmessung überarbeitet und es finden sich aufbereitete Informationen zum Betrieb von Windkraftanlagen im elektrischen Verbundnetz. Grundsätzlich war dieses Buch als Vorlesung-begleitendes Material gedacht und ist nun zu einem deutschen Standardwerk für Windkraftanlagen geworden. Das Buch ist sehr verständlich und nachvollziehbar aufgebaut. Grundkenntnisse In Aerodynamik und Strömungsmechanik sind von Vorteil. Es eignet sich hervorragend zum Selbststudium und ist bis jetzt das einzige auf dem deutschen Markt. Windkraftanlagen: Grundlagen, Entwurf, Planung und Betrieb von Jochen Twele (Herausgeber), Robert Gasch (Herausgeber), R. Gasch (Mitarbeiter), J. Twele (Mitarbeiter), Wolfgang Conrad (Mitarbeiter), Christoph Heilmann (Mitarbeiter), K. Kaiser (Mitarbeiter), Rüdiger Kortenkamp (Mitarbeiter), Martin Kühn (Mitarbeiter), W. Langreder (Mitarbeiter), Jan Liersch (Mitarbeiter), J. Maurer (Mitarbeiter), A. Reuter (Mitarbeiter), Mathias Schubert (Mitarbeiter), Bastian Sundermann (Mitarbeiter), Alexander Stoffel (Mitarbeiter) Windkraftindustrie Windmessung Windmessung Windkraftbranche Aerodynamik Strömungsmechanik In deutscher Sprache. 569 pages. 24 x 17 x 3,2 cm Auflage: 5, bearb. u. erg. Aufl. 2007 (26. Juli 2007).
EUR 7,90
Quantità: 1 disponibili
Aggiungi al carrelloCondizione: Sehr gut. Zustand: Sehr gut | Seiten: 1510 | Sprache: Deutsch | Produktart: Bücher | Keine Beschreibung verfügbar.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 94,25
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Da: Brook Bookstore On Demand, Napoli, NA, Italia
EUR 126,26
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Springer Berlin Heidelberg Mai 2012, 2012
ISBN 10: 3642261434 ISBN 13: 9783642261435
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 117,69
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field. 248 pp. Englisch.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 2012
ISBN 10: 3642261434 ISBN 13: 9783642261435
Da: moluna, Greven, Germania
EUR 98,54
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A general overview of the latest developments in angiogenesis inhibition in cancerConsiders all aspects from the bench to the bedside, with detailed attention both to basic research and to its translation into clinical practicePresents the .
Lingua: Inglese
Editore: Springer, J.B. Metzler Mai 2012, 2012
ISBN 10: 3642261434 ISBN 13: 9783642261435
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 117,69
Quantità: 1 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 248 pp. Englisch.
Lingua: Inglese
Editore: Springer, J.B. Metzler Nov 2009, 2009
ISBN 10: 354078280X ISBN 13: 9783540782803
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
EUR 160,49
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field. 248 pp. Englisch.
Lingua: Inglese
Editore: Springer Berlin Heidelberg, 2009
ISBN 10: 354078280X ISBN 13: 9783540782803
Da: moluna, Greven, Germania
EUR 132,75
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. A general overview of the latest developments in angiogenesis inhibition in cancerConsiders all aspects from the bench to the bedside, with detailed attention both to basic research and to its translation into clinical practicePresents the .
Lingua: Inglese
Editore: Springer, Springer Nov 2009, 2009
ISBN 10: 354078280X ISBN 13: 9783540782803
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
EUR 160,49
Quantità: 1 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Angiogenesis is attracting increased scientific and clinical interest. The identification of novel mediators and targeting molecules has led to significant progress in our understanding of tumor angiogenesis and tumor vessel targeting. Important advances in cancer treatment have already emerged, and in the future, blood vessel targeting will play a significant role within individualized therapeutic strategies. This volume provides a general overview of the latest developments in angiogenesis inhibition in cancer. All aspects from the bench to the bedside are considered, with detailed attention both to basic research and to its translation into clinical practice. Individual chapters are devoted to the roles of angiopoietins, HIF-1a, chemokines, PDGF and VEGF, and vascular integrins. The latest results of clinical trials are presented, and various advanced targeting strategies are discussed. This book will be invaluable to all who wish to learn of the most recent advances in this exciting field.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 248 pp. Englisch.
Da: Majestic Books, Hounslow, Regno Unito
EUR 242,21
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. Print on Demand pp. 248 47 Illus. (22 Col.).
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 245,95
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New. PRINT ON DEMAND pp. 248.